Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,876,910 papers from all fields of science
Search
Sign In
Create Free Account
EDTMP
Known as:
Ethylenediamine Tetra(methylene Phosphonic Acid)
, LEXIDRONAM
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
SAMARIUM Sm153 50 MCI/ML Injectable Solution [Quadramet]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
T. Das
,
H. D. Sarma
,
A. Shinto
,
K. Kamaleshwaran
,
S. Banerjee
Cancer Biotherapy and Radiopharmaceuticals
2014
Corpus ID: 22045051
OBJECTIVE The objective of the present work was to develop a freeze-dried ethylenediaminetetramethylene phosphonic acid (EDTMP…
Expand
2011
2011
Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.
Jianqing Lin
,
V. Sinibaldi
,
+4 authors
M. Eisenberger
Urologic oncology
2011
Corpus ID: 35832392
Review
2011
Review
2011
Adverse events in the long-term follow-up of patients treated with samarium Sm 153 lexidronam for osseous metastases.
A. Paravati
,
A. Russo
,
C. Aitken
International Journal of Radiation Oncology…
2011
Corpus ID: 32536984
2010
2010
Production, Quality Control and Pharmacokinetic Studies of 166Ho-EDTMP for Therapeutic Applications
A. Bahrami-Samani
,
R. Bagheri
,
A. Jalilian
,
S. Shirvani-Arani
,
M. Ghannadi‐Maragheh
,
M. Shamsaee
Scientia Pharmaceutica
2010
Corpus ID: 13822400
166Ho-EDTMP is a major therapeutic agent which is widely used in bone palliation therapy. In this study, a 166Ho-EDTMP complex…
Expand
2010
2010
Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
D. Máthé
,
L. Balogh
,
+6 authors
G. Jánoki
Nuclear Medicine and Biology
2010
Corpus ID: 33295158
2008
2008
153Sm: its use in multiple myeloma and report of a clinical experience
E. Abruzzese
,
F. Iuliano
,
M. Trawinska
,
Massimo Di Maio
Expert Opinion on Investigational Drugs
2008
Corpus ID: 19618001
Background: In the past years the bone seeking radiopharmaceutical samarium lexidronam (153Sm-EDTMP) has been increasingly used…
Expand
2007
2007
Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005).
Sandra M. Barnard
,
R. Max Zuber
,
Antony S. Moore
Journal of the American Veterinary Medical…
2007
Corpus ID: 24864001
OBJECTIVE To evaluate survival times and palliative effects associated with the use of samarium Sm 153 lexidronam in dogs with…
Expand
2002
2002
153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies
D. MacFarlane
,
S. Durrant
,
M. Bartlett
,
R. Allison
,
A. Morton
Nuclear medicine communications
2002
Corpus ID: 23755842
This study examined the safety of adding 153Sm lexidronam to standard conditioning regimens in patients undergoing stem cell…
Expand
1997
1997
The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. The ISOLDE Collaboration.
G. Beyer
,
R. Offord
,
+6 authors
M. Lindroos
Nuclear Medicine and Biology
1997
Corpus ID: 36132496
Highly Cited
1996
Highly Cited
1996
Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.
Øyvind S. Bruland
,
Arne Skretting
,
Øyvin P. Solheim
,
Magne Aas
Acta oncologica
1996
Corpus ID: 38479658
We report a case where targeted radionuclide therapy using 153Sm-EDTMP gave substantial palliative effect. A 35-year-old male…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE